In remarks at the Families USA Health Action Conference in Washington DC on January 22, US Senator Elizabeth Warren (Democrat, Massachusetts) announced plans to introduce new legislation to advance medical research.
She said: "The first problem is the government. Congress used to work in a non-political, bipartisan way to expand NIH [National Institutes of Health] funding. But since the early 2000s, Congress has been strangling the funding needed for medical research....The second problem is with the drug companies. Over the last 10 years, some of our wealthiest drug companies - those that capitalize on government research to generate billions of dollars in revenues through the sale of blockbuster drugs- have found another way to boost profits."
Sen Warren then laid out her plan to introduce a bill that would help strengthen the federal investment in critical medical research, saying: "Next week, I plan to introduce legislation - the Medical Innovation Act - that would substantially increase federal funding for the National Institutes of Health."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze